Zombie Aquaa,,cents Fixable Viability Kit

BioLegend Inc. was awarded contract A207_PO-0474110 by the University of Virginia on August 27, 2026, with a cumulative contract value of $62. The prime contractor will deliver products and/or services to the University of Virginia, a state institution in Virginia. While the specific scope of work, detailed deliverables, and period of performance are not specified in the available documentation, BioLegend Inc.'s core business activities in life sciences research suggest the contract likely involves provision of research reagents, antibodies, flow cytometry reagents, or related laboratory supplies commonly procured by academic research institutions.

The contract represents a purchase order arrangement, as indicated by the PO designation in the award identifier. However, the minimal contract value and lack of detailed performance metrics, delivery schedules, or statement of work specifications preclude comprehensive characterization of the engagement scope. Additional contract documentation would be required to provide complete details regarding deliverables, performance period, and specific products or services being supplied under this award.